CA12 - Le fibroscan® permet le diagnostic non-invasif de la fibrose hépatique chez l’enfant : comparaison prospective avec le fibrotest et la ponction-biopsie hépatique

Lamireau, T.; Bail, Brigitte Le; Rebouissoux, Laurent; Foucher, Juliette; Castéra, Laurent; Darriet, Monique; Lédinghen, Victor de

doi:10.1016/s0399-8320(05)86409-7

Cited by 3 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A special probe for paediatrics is under development. In the study by Lamireau et al [33], the diagnostic value of the Fibroscan was comparable to that of the Fibrotest-Actitest, although the conclusions were somewhat restricted by the low number of children analysed [33].…”

Section: Cirrhosismentioning

confidence: 86%

Noninvasive diagnosis of liver fibrosis by ultrasonic transient elastography (Fibroscan)

Nguyen‐Khac

Capron

2006

European Journal of Gastroenterology & Hepatology

View full text Add to dashboard Cite

Methods for diagnosing hepatic fibrosis have progressed significantly over the last few years--notably with the appearance of minimally invasive biological tests (which avoid the need for liver needle biopsy but nevertheless require a blood sample). Hepatic ultrasonic transient elastography (Fibroscan) is a new diagnostic method for hepatic fibrosis: it is totally noninvasive and gives an immediate result. Here, we review the currently available data on the use of the Fibroscan. Today's main field of application is chronic, viral hepatitis C, with areas under the receiver operation characteristic curve of 0.79-0.83, 0.90-0.91 and 0.91-0.97 for the diagnosis of F2, F3 and F4 fibrosis (defined according to the Metavir classification system), respectively. Furthermore, the Fibroscan enables the noninvasive diagnosis of cirrhosis (regardless of the latter's aetiology), with positive and negative predictive values of 70-95% and 77-95%, respectively. Chronic viral hepatitis B, HIV-hepatitis C virus and HIV-hepatitis B virus coinfections, alcohol-related liver diseases and intrahepatic cholestatic diseases are the device's other main fields of application in hepatology. Today, the Fibroscan is a reliable alternative for the noninvasive diagnosis of hepatic fibrosis. Various diagnostic strategies and performing cost/benefit analyses are now necessary, to assess fully the value of hepatic elastography relative to biological tests for hepatic fibrosis.

show abstract

Section: Cirrhosismentioning

confidence: 86%

Noninvasive diagnosis of liver fibrosis by ultrasonic transient elastography (Fibroscan)

Nguyen‐Khac

Capron

2006

European Journal of Gastroenterology & Hepatology

View full text Add to dashboard Cite

show abstract

Résultats et place du Fibroscan® dans le diagnostic non invasif de la fibrose hépatique

Nguyen‐Khac¹

2007

La Revue de Médecine Interne

View full text Add to dashboard Cite

Intérêt de l’élastométrie (FibroScan®) pour l’évaluation non invasive de la fibrose hépatique

Castéra¹

2007

Gastroentérologie Clinique et Biologique

View full text Add to dashboard Cite

CA12 - Le fibroscan® permet le diagnostic non-invasif de la fibrose hépatique chez l’enfant : comparaison prospective avec le fibrotest et la ponction-biopsie hépatique

Cited by 3 publications

References 0 publications

Noninvasive diagnosis of liver fibrosis by ultrasonic transient elastography (Fibroscan)

Noninvasive diagnosis of liver fibrosis by ultrasonic transient elastography (Fibroscan)

Résultats et place du Fibroscan® dans le diagnostic non invasif de la fibrose hépatique

Intérêt de l’élastométrie (FibroScan®) pour l’évaluation non invasive de la fibrose hépatique

Contact Info

Product

Resources

About